Critically ill COVID-19 Patient Successfully Treated with Vitro Biopharma’s AlloRx Stem Cells(R)

July 14, 2020 6:00 AM

GOLDEN, CO / ACCESSWIRE / July 14, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma, jointly with GIOSTAR - a San Diego, California-based institution headed by Dr. Anand Srivastava, a pioneer in stem cell science - announced the results of treatment of a critically ill COVID-19 patient with its lead clinical product AlloRx Stem Cells®. This patient was admitted to an emergency room with classic COVID-19 symptoms in late...

Read more

Tetra Bio-Pharma Appoints Steve Edgett As A Strategic Advisor

July 9, 2020 8:00 AM

OTTAWA / ACCESSWIRE / July 9, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has appointed Steve Edgett as a Strategic Advisor. Mr. Edgett will act as a special advisor to the CEO and the Board of Directors with a mandate to advise on strategic and capital markets aspects of the Company's...

Read more

Molecular Partners to Collaborate with AGC Biologics for Manufacturing of Anti-COVID-19 DARPin(R) Program

July 9, 2020 1:00 AM

Partnership secures initial clinical and commercial-scale microbial manufacturing capacity The only tri-specific antiviral protein in development, with potential best-in-class potency Clinical studies planned for Q4 2020 ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / July 9, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin®...

Read more

Completion of Name Change and Share Consolidation

July 8, 2020 3:00 PM

VANCOUVER, BC / ACCESSWIRE / July 8, 2020 / CANAM BIOTECH INC. (formerly, Hemagenetics Technologies Corp.) (the "Company") is pleased to announce that effective July 7, 2020 it has completed its name change from "Hemagenetics Technologies Corp." to "Canam Biotech Inc." and the consolidation of its issued and outstanding Common Shares on the basis of 75 pre-consolidation shares for each 1 post-consolidation share for...

Read more

Quanta Announces "Town Hall" Style Shareholder Update for July 15, 2020 at 1:30 PM ET

July 8, 2020 2:10 PM

BURBANK, CA / ACCESSWIRE / July 8, 2020 / Quanta, Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual "Town Hall" style investor event, which will be broadcast live over the internet on July 15, 2020 at 1:30 PM ET / 10:30 AM PT. Eric Rice, the company's Chief Executive Officer, will...

Read more

DECN Announces Distribution Agreement Covering GenViro! Covid-19:10.5 Swift Kits and Its GenUltimate and TGB Products in India, Malaysia, Sri Lanka, Singapore, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia

July 8, 2020 9:15 AM

COMPANY ALSO ANNOUNCES IT IS CURRENTLY EVALUATING ADDITIONAL AGREEMENTS FOR DISTRIBUTION OF GENVIRO! SWIFT KITS IN BRAZIL, ARGENTINA, NIGERIA AND THE PHILIPPINES, AND THAT IT HAS FILED A PROVISIONAL PATENT FOR ITS GENULTIMATE TBG PRODUCT LOS ANGELES, CA / ACCESSWIRE / July 8, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it has entered into a written distribution...

Read more

Dyadic Announces Two New Fully Funded Collaborations with Leading Global Animal Health Companies

July 8, 2020 8:30 AM

Dyadic Now Partnered with all of the Top Four Animal Health CompaniesFive Fully Funded Animal Health Research Projects with Three New Relationships Announced this YearJUPITER, FL / ACCESSWIRE / July 8, 2020 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate the development,...

Read more

Apollo Endosurgery Announces 510k Submission for the X-Tack(TM) Endoscopic HeliX Tacking System for the Treatment of Gastrointestinal Defect Closures

July 7, 2020 7:30 AM

AUSTIN, TX / ACCESSWIRE / July 7, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the 510k submission of the X-Tack™ Endoscopic HeliX Tacking System to the U.S. Food and Drug Administration seeking clearance for the new, through-the-scope, suture-based device designed specifically for closing defects in the...

Read more

Molecular Partners Successfully Completes the Launch of a Private Placement of 5,528,089 Shares by way of an Accelerated Bookbuilding

July 6, 2020 7:05 PM

Proceeds from the Offering will help accelerate development of the SARS-CoV-2 antiviral candidate, MP0420, as well as early stage clinical and preclinical pipeline assets ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / July 6, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that it has successfully placed...

Read more

DECN CEO Offers Open Letter on COVID-19 Testing Highlighting Needed Support for Innovation in Testing

July 2, 2020 10:15 AM

CEO asks the critical question, "Why is there such a slow march to accept Novel Covid-19 testing methodologies?" LOS ANGELES, CA / ACCESSWIRE / July 2, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today produced an "Open Letter" outlining the need for greater and faster support for innovative solutions to the Covid-19 testing needs of the country. As a leading...

Read more

Wuhan General Group Signs Collaborative Partnership LOI With Jugular for CBD Functional Foods

July 1, 2020 8:45 AM

MONTREAL, QC / ACCESSWIRE / July 1, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce, that effective June 30th, 2020, it has signed a letter of intent to pursue a Partnership where Jugular will support and offer its expertise to the Company in creating a specialized...

Read more

Xenetic Biosciences, Inc. Provides Development Update for Its Personalized CAR T Platform Technology, XCART(TM)

July 1, 2020 8:05 AM

XCART technology platform is a significantly differentiated, proprietary approach to personalized CAR T therapy for the treatment of multiple tumor types of B-cell Non-Hodgkin lymphoma (NHL) Recently secured two academic collaborations to advance development of XCART Company strategically well-positioned to execute on pathway to advance the XCART platform technology through preclinical development and potentially into a Phase 1...

Read more

Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index

June 29, 2020 8:00 AM

JUPITER, FL / ACCESSWIRE / June 29, 2020 / Dyadic International, Inc. ("Dyadic") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, announced today that the Company will be added to the small-cap Russell 2000® Index and...

Read more

American CryoStem Announces the Conversion of Debenture into Equity and Sale into the Market

June 29, 2020 7:00 AM

The debt issuance has been executed in accordance with the terms of the Debenture contained in the Company's 10-Q through the issuance of common shares in order to preserve cash available to fund ongoing operations. As the US economy improves and physicians' offices re-open the Company foresees its cGMP laboratory processing cellular samples by late summer despite the Covid-19 pandemic and its associated shutting down of the American...

Read more

ABMC Reports Fourth Quarter and Year End 2019 Results

June 26, 2020 5:00 PM

KINDERHOOK, NY / ACCESSWIRE / June 26, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2019. Chief Executive Officer, Melissa A. Waterhouse stated, "While sales did not increase in Q4 2019 (as they did in Q3 2019), they were relatively flat. In 2019, sales in our core markets declined, some of which was due to timing of shipments to customers at...

Read more

Quanta Inc Launches New molequle Brand for Amazon

June 25, 2020 8:30 AM

BURBANK, CA / ACCESSWIRE / June 25, 2020 / Quanta Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, announced the launch of molequle, a new skincare brand initially featuring masks and under eye patches. The products, made with all-natural ingredients and featuring Quanta's polarization technology, are slated to debut...

Read more

Tetra Bio-Pharma Announces Stock Option Grant

June 25, 2020 8:00 AM

OTTAWA / ACCESSWIRE / June 25, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP) (OTCQB:TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, is pleased to announce the grant of an aggregate of 1,535,583 stock options (each, an "Option") to certain Officers, consultants and employees of the Company in accordance with the Company's shareholder approved stock...

Read more

Wuhan General Group Signs Manufacturing, Distribution and Sales Agreement with Cafféluxe

June 24, 2020 8:30 AM

MONTREAL, QC / ACCESSWIRE / June 24, 2020, / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce, that effective June 22nd, 2020, it has entered into a manufacturing, distribution and sales agreement with Cafféluxe for an initial two-year term. Under the terms of this...

Read more

Tetra Bio-Pharma Announces Change to its Board of Directors

June 22, 2020 8:00 AM

Change represents evolving board capabilities as Tetra enters next stage of its corporate development OTTAWA, ON / ACCESSWIRE / June 22, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, today announces the departure of one of its members of the Board of Directors (the "Board). The Tetra...

Read more

Wuhan General Group Announces Name Change and Rebranding to M2Bio Sciences

June 18, 2020 8:30 AM

MONTREAL, QC / ACCESSWIRE / June 18, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce a corporate name change and rebranding of the company to M2Bio Sciences, Inc ("M2Bio"). The name change was effective June 17, 2020, with the State of Nevada. In addition...

Read more